EUVIMEDEUVIMED entdecken
Open Access

Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation

Zhaohuan Wang iD, Manman Qiu, Yue Ji, Keli Chai, Chenxi Liu, Fengwen Xu, Fei Guo, Juan Tan, Ruikang Liu iD, Wentao Qiao iD

Journal of Virology · 22.10.2024 · 98 (10)

DOI: 10.1128/jvi.01072-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 22.10.2024. Verfasst von Zhaohuan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Lipoylation, SARS-CoV-2, Virus Assembly, Coronavirus Envelope Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key international Cooperation Project of the National Key Research and Development Program of China, CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Envelope (E) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an integral structural protein in the virus particles. However, its role in the assembly of virions and the underlying molecular mechanisms are yet to be elucidated, including whether the function of E protein is regulated by post-translational modifications. In the present study, we report that SARS-CoV-2 E protein is palmitoylated at C40, C43, and C44 by palmitoyltransferases zDHHC3, 6, 12, 15, and 20. Mutating these three cysteines to serines (C40/43/44S) reduced the stability of E protein, decreased the interaction of E with structural proteins Spike, Membrane, and Nucleocapsid, and thereby inhibited the production of virus-like particles (VLPs) and VLP-mediated luciferase transcriptional delivery. Specifically, the C40/43/44S mutation of E protein reduced the density of VLPs. Collectively, these results demonstrate that palmitoylation of E protein is vital for its function in the assembly of SARS-CoV-2 particles. IMPORTANCE In this study, we systematically examined the biochemistry of palmitoylation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) E protein and demonstrated that palmitoylation of SARS-CoV-2 E protein is required for virus-like particle (VLP) production and maintaining normal particle density. These results suggest that palmitoylated E protein is central for proper morphogenesis of SARS-CoV-2 VLPs in densities required for viral infectivity. This study presents a significant advancement in the understanding of how palmitoylation of viral proteins is vital for assembling SARS-CoV-2 particles and supports that palmitoyl acyltransferases can be potential therapeutic targets for the development of SARS-CoV-2 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoylationSARS-CoV-2Virus AssemblyCoronavirus Envelope ProteinsVirionAcyltransferasesHumansCOVID-19HEK293 CellsProtein Processing, Post-TranslationalSpike Glycoprotein, CoronavirusMutation

Stichwörter der Autor:innen

Envelope proteinSARS-CoV-2palmitoylationvirus-like particles

Substanzen

Coronavirus Envelope Proteinsenvelope protein, SARS-CoV-2AcyltransferasesZDHHC3 protein, humanZDHHC20 protein, humanSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China.
  • NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
  • Department of Pathogenic Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

ORCID-Profile: Zhaohuan Wang, Ruikang Liu, Wentao Qiao

Förderung

  • Key international Cooperation Project of the National Key Research and Development Program of China
  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China (NSFC)
  • Fundamental Research Funds for the Central Universities, Nankai University

Zitieren

APA

Wang, Z., Qiu, M., Ji, Y., Chai, K., Liu, C., Xu, F., Guo, F., Tan, J., Liu, R., & Qiao, W. (2024). Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation. Journal of Virology, 98(10). https://doi.org/10.1128/jvi.01072-24

Vancouver

Wang Z, Qiu M, Ji Y, Chai K, Liu C, Xu F, et al. Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation. Journal of Virology. 2024;98(10). doi:10.1128/jvi.01072-24

BibTeX
@article{Wang2024,
  author = {Wang, Zhaohuan and Qiu, Manman and Ji, Yue and Chai, Keli and Liu, Chenxi and Xu, Fengwen and Guo, Fei and Tan, Juan and Liu, Ruikang and Qiao, Wentao},
  title = {Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {10},
  doi = {10.1128/jvi.01072-24}
}
Kostenlos starten →